Quest Diagnostics delivered a Q4 performance that exceeded Wall Street’s revenue and earnings expectations, prompting a positive market reaction. Management attributed this outcome to strong organic ...
Quest Diagnostics recently unveiled a suite of advanced diagnostics and support services designed to broaden access to lab tests for transplants. Quest hopes to improve testing compliance among ...
Feb 10 () - Quest Diagnostics on Tuesday forecast 2026 profit and revenue above Wall Street ​estimates after beating ...
Quest Diagnostics named Dr. Yuri Fesko, a seasoned health care executive and oncologist, its new senior vice president and chief medical officer. In a Dec. 20 press release announcing the appointment, ...
Analysts estimate that Quest Diagnostics will report an earnings per share (EPS) of $2.35. Anticipation surrounds Quest ...
Quest Diagnostics Incorporated (NYSE:DGX) Q4 2025 Earnings Call Transcript February 10, 2026 Quest Diagnostics Incorporated ...
Shares of Quest Diagnostics (DGX) reached a new 52-week high on Tuesday after the diagnostic services provider exceeded Street forecasts with its Q4 2025 financials and set its 2026 outlook above the ...
The relationship between Quest Diagnostics and Hackensack Meridian Health is taking another test. For the last four years, the Secaucus-based lab services provider has managed laboratory operations ...
[Updated 5/15/2020] Is Quest Diagnostics Or LabCorp The Better Diagnostic Play In The COVID Era? As the U.S. re-opens its economy while trying to contain the spread of the contagious viral infection, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results